The increasing frequency of copper (Cu) toxicosis episodes in cattle in recent years, mainly associated with excess Cu supplementation, underscores the need to identify animals in the clinically silent phase of hepatic Cu accumulation. The aim of the study reported here was to evaluate the suitability of various blood parameters as potential early markers of hepatic Cu accumulation in cattle. Paired liver and blood samples from 70 calves aged 6 to10 months were obtained at slaughter in a region in northwestern Spain where animals usually have hepatic Cu concentration higher than safe values. Neither serum Cu concentration nor ceruloplasmin (CP) concentration, the 2 parameters most commonly used for diagnosis of Cu deficiency, were significantly associated with hepatic Cu concentration. However, whole-blood Cu concentration had a slight but significant correlation with hepatic Cu concentration (r ϭ 0.269, P ϭ 0.026). The use of calculated blood parameters, such as the serum or whole-blood non-CP Cu fraction, or the CP-to-serum Cu ratio, increased the correlation with the hepatic Cu concentration (r ϭ 0.393, P ϭ 0.001, in the case of whole-blood, non-CP Cu concentration), but the strength of the association remained insufficient for accurate prediction of hepatic Cu values. Likewise, hepatic enzyme (aspartate transaminase and ␥-glutamyltransferase) activities were significantly or nearly correlated significantly with hepatic Cu concentration, but the strength of the association remained too low for accurate prediction. It is concluded that direct analysis of Cu concentration in liver biopsy specimens-preferably postmortem liver samples obtained at slaughter-is the best technique currently available for detecting chronic subclinical Cu accumulation in cattle at risk for supraoptimal Cu exposure.
Introduction
Traditionally, it has been thought that cattle are relatively tolerant of copper (Cu) exposure, 8, 15, 20 and reports of Cu poisoning have been rare. In recent years, however, an increasing number of episodes of Cu toxicosis have been reported in cattle, 6, 23, 40 even at Cu concentrations well below those regarded as toxic in the literature. 17, 29 In most instances, Cu toxicosis in cattle is associated with excess Cu intake in the ration, as well as with changes in the type and bioavailability of dietary Cu supplements. 14, 24 It also has been reported that dietary supplements leading to Cu accumulation in the liver at concentration only slightly above normal (around 125 mg/kg of wet weight) induce negative effects on animal performance, in terms of reduced feed intake and average daily gain. 11 Liver Cu concentration that seemingly could be associated with subclinical chronic Cu toxicosis in cattle has been observed in many countries where Cu supplements are given at concentration that is well above requirements, 18, 22 or where there is contamination of pastures Universidade de Santiago de Compostela, Departamento de Patoloxía Animal, Facultade de Veterinaria, 27002 Lugo, Spain. 1 Corresponding Author: Marta López-Alonso, Department Animal Pathology, Veterinary Faculty, 27002 Lugo, Spain. as a result of mining, industrial emissions, or use of organic wastes as fertilizer, especially pig slurry. 25, 38 Chronic Cu poisoning in cattle is a two-stage process. 20 The first stage is the prehemolytic phase, during which Cu accumulates in the liver without clinical signs of disease being manifested. Only when the liver's capacity to accumulate Cu is overloaded, usually following a stressful event of some sort, does substantial liver degeneration develop. Copper is then released from the liver, usually causing a hemolytic crisis. 20 The clinically silent phase of the disease makes diagnosis difficult until the animal experiences a hemolytic crisis. In fact, in a recent study of herds with clinical Cu toxicosis, the clinical cases represented only a small proportion of the actual cases of Cu poisoning. 23 Identification of animals in this silent, chronic phase of Cu accumulation is important to avoid not only economic losses due to subsequent severe disease or death, but also to avoid subclinical disease, and to adapt Cu supplementation to physiologic needs.
Currently available laboratory markers of Cu toxicosis in humans and animals are mainly used for diagnostic purposes (i.e., to document changes associated with clinical manifestations already present). 1, 28 However, there is a clear need to identify markers of early changes, with a capacity to predict risk of Cu accumulation in the liver before actual tissue or func- tional damage develops. Acquisition of these markers should be noninvasive, or at least less invasive than liver biopsy, and the markers should function as a sensitive index of Cu accumulation even in the absence of substantial functional damage. 32 The aim of the study reported here was to evaluate the suitability of some blood parameters as potential markers of hepatic Cu accumulation in calves in a region of northwestern Spain where animals often have hepatic Cu concentration above the normally accepted ''safe'' values. 25 
Materials and Methods
Animals. Paired liver and blood samples were obtained from 70 calves aged 6 to 10 months. These animals were randomly selected from a larger sample (n ϭ 530) used to assess hepatic Cu concentration in beef cattle in Galicia (northwestern Spain). In this region, beef cattle are mostly raised on small farms, with outdoor grazing throughout the year on pastures typically fertilized with pig slurry, so that Cu exposure is often high.
Sample collection. Liver and blood samples were collected in December 2001 during ordinary slaughter of the animals. Blood samples were obtained from the jugular vein. For whole-blood Cu determination, samples were collected into 5-ml, evacuated, heparinized tubes. Clotted blood (20 ml) also was obtained to evaluate serum Cu, ceruloplasmin (CP) activity, and hepatic enzyme activities. Liver samples (about 200 g) were taken from the caudal lobe immediately after slaughter. Samples were placed on ice immediately after collection, and were transported to the laboratory for further preparation. Serum was obtained by centrifugation (3,000 ϫg for 15 minutes) of clotted samples within 6 hours after collection. Three aliquots of serum and heparinized blood (2 ml) for Cu determination were stored in acidwashed (10% nitric acid) tubes at Ϫ20ºC. Liver samples were homogenized, and subsamples of approximately 20 g in triplicate were frozen until analysis.
Sample analysis. Liver (2 g) and heparinized whole blood (2 ml) samples for Cu determination were acid digested with concentrated nitric acid and hydrogen peroxide in a microwave digestion system. a Serum samples were deproteinated with 10% trichloroacetic acid. Copper concentration was measured by use of inductively coupled plasma optical emission spectroscopy (ICP-OES b ). Ceruloplasmin activity was measured according to its p-phenylenediamine oxidase activity. 34 The nonceruloplasmin (non-CP) fraction of Cu in whole blood and serum was calculated by subtracting the amount of Cu in CP (assuming a molecular weight of 132,000 Da and 6 Cu atoms/molecule 13 ).
Activities of the liver specific enzymes aspartate transaminase (AST), ␥-glutamyltransferase (␥-GT), and alkaline phosphatase (ALP) were measured in serum by use of standard procedures and a commercial diagnostic kit. c Statistical analysis. All statistical analyses were performed using SPSS for Windows (v.12.0). d Normal distribution of data sets was examined using the Kolmogorov-Smirnov test. Serum activities of ␥-GT and ALP did not have a normal distribution, so the data were logarithmically transformed before analysis. Association between hepatic Cu accumulation and each of the blood parameters analyzed was assessed using the Pearson correlation coefficient.
Results
The data for hepatic, whole-blood and serum Cu concentrations, and serum CP concentration are summarized in Table 1 . Hepatic Cu concentration in the calves of this study ranged from 4 to 330 mg/kg of wet weight, with a mean Ϯ SEM of 112 Ϯ 7 mg/kg of fresh weight; two-thirds (46/70) of the samples analyzed had Cu concentration above the generally accepted adequate value for cattle liver (25 to 100 mg/ kg of wet weight 30 ).
Mean whole-blood and serum Cu concentrations were 0.967 Ϯ 0.170 and 0.702 Ϯ 0.177 mg/liter, respectively; all 70 calves had whole-blood and serum Cu values above the generally accepted lower limits of adequacy: 0.667 and 0.476 mg/liter, 36 respectively. All serum Cu concentrations were found to be Ͻ3 mg/ liter, 6 the minimal concentration associated with clinical toxicosis. Mean serum CP concentration was 142 Ϯ 5 mg/ liter; 7 of the 70 samples (10%) had CP concentration below the adequate range in serum (90 to 250 mg/ liter 30 ), although in all of these animals, hepatic Cu concentration was very high (Ͼ120 mg/kg of wet weight).
With regard to the feasibility of using these blood Cu parameters to predict Cu accumulation in the liver, only whole-blood Cu concentration had a statistically significant correlation with Cu accumulation in the liver ( Table 2) . Table 1 also summarizes data for the calculated parameters (non-CP whole blood and serum Cu concentration) and the ratio of serum CP concentration to serum Cu concentration (CP : Cu). Copper concentration in the liver was positively correlated with the non-CP fraction in serum and whole blood, and negatively correlated with serum CP : Cu; using these indirect blood Cu parameters slightly increases the strength of the association with hepatic Cu accumulation ( Table  2 ).
In general, hepatic enzymatic activities were within reference intervals, as regularly determined in our laboratory (AST Ͻ80 U/liter; ␥-GT Ͻ17 U/liter; ALP Ͻ200 U/liter [ Table 1 ]). Despite this, there was significant correlation between hepatic Cu accumulation and serum AST activity, and nearly significant correlation (P ϭ 0.063) with serum ␥-GT activity ( Table 2) .
Discussion
Results of this study indicate that, in cattle with moderate hepatic Cu accumulation, neither the serum Cu nor CP concentration, the 2 main parameters typically used in the diagnosis of Cu deficiency in cattle, 37, 42 are significantly associated with hepatic Cu concentration. Several authors have reported that serum/plasma Cu concentration is a poor indicator of Cu loading of the liver. 3, 39 In fact, animals considered to be deficient or in the low-normal part of the reference interval, on the basis of evaluation of serum Cu concentration, have been found to be at or near a toxic state on the basis of necropsy results or examination of hepatic biopsy specimens. 7 It is only when liver stores reach a critical threshold that acute hepatic necrosis develops, releasing liver Cu stores and causing transient high serum Cu concentration. 37 In serum or plasma, Cu is present in 3 major forms, in 2 pools between which Cu does not appear to be exchangeable: the main pool containing Cu as CP, corresponding to Cu exported from the liver to tissues; and a second pool containing Cu in albumin-and amino acid-bound forms, mainly corresponding to Cu transported from the intestine to the liver in the portal circulation. 9 Results of the study reported here, like those of other studies, 7, 33 have indicated that hepatic Cu and CP concentrations are not correlated at either normal or high amounts of hepatic Cu accumulation. This is because, once the animal's liver reaches adequate Cu status, CP as well as Cu-dependent enzymes such as superoxide dismutase in erythrocytes attain maximal activity that is not increased with further hepatic Cu accumulation 4, 31 ; in addition, CP values vary with factors, such as age and sex, 12, 27 and increase rapidly in response to factors other than Cu excess, such as exercise and various inflammatory and infection conditions. 5, 19 Whole-blood Cu concentration, although nowadays not commonly used for assessing animal Cu status, 36 might be a better indicator of Cu accumulation in the liver, as suggested by results of the study reported here. In fact, a recent study of potential biomarkers of Cu overexposure indicated that Cu is able to bind with high affinity to some erythrocyte proteins 32 ; however, further research is still necessary to better characterize these proteins and validate their use as markers of Cu exposure.
In an attempt to find potential markers of Cu exposure, and taking into account that CP, the main Cucontaining component in blood, is affected by factors other than Cu exposure, the non-CP fraction (a calculated value) recently has been used as a marker of Cu exposure in humans. 1, 10 It has been documented that serum non-CP Cu values are positively correlated with total serum Cu concentration in humans receiving high dietary Cu and in patients with high Cu load (such as that associated with Wilson's disease and other forms of childhood cirrhosis). The non-CP Cu fraction was also highly correlated with serum Cu concentration (r ϭ 0.649, P ϭ 0.000) in this study, and most importantly, the serum and the whole-blood, non-CP fraction were significantly associated with Cu concentration in the liver. However, the strength of these associations, though better than that between whole-blood and hepatic Cu concentrations, is still too low for accurate prediction of Cu accumulation in the liver.
Another parameter that has been proposed as a marker of Cu deficiency status in ruminants is the serum CP : Cu value. 2, 26 In our study, that value was negatively correlated with hepatic Cu concentration, indicating that, as Cu accumulation increases in the liver, proportionally less Cu in serum is bound to CP; in any case, the strength of the association observed between the serum CP : Cu value and hepatic Cu concentration was lower than that between the non-CP fraction Cu and hepatic Cu values.
Hepatic enzyme activities, together with Cu concentration in blood, liver, and kidney, are among the most widely used clinical tools for diagnosis of chronic Cu toxicosis, 3, 6 because hepatic necrosis leads to a sudden release of hepatic enzymes into the blood during the terminal stages of Cu poisoning. Several authors have postulated that hepatic enzymes may also be useful early markers during the long-term, subclinical phase of hepatic Cu accumulation, 21, 23 on the basis of the fact that, during this silent phase, some cells undergo necrosis, leading to increases in enzyme activities in the blood. However, in line with the present results, other authors 35, 41 have found only weak correlation between serum enzyme activities and hepatic Cu values or clinical manifestations of hepatic insufficiency. During the chronic progressive hepatic Cu accumulation phase, only a few hepatocytes undergo necrosis at any specific time (0.45% of liver volume) 16 ; thus, such increases are transitory, and unless samples are obtained at least once a week, these increases may not be detected. 20, 28 In conclusion, assuming that all of the animals of this study were exposed to moderately high dietary Cu concentration, none of the targeted blood markers accurately predicted hepatic Cu accumulation. Analysis of Cu content in the liver is probably the best diagnostic tool currently available for assessing the risk of chronic Cu toxicosis. To this end, hepatic biopsy specimens should be regularly obtained from animals at risk for Cu poisoning (e.g., highly Cu-supplemented diet or grazing in contaminated areas). Obviously, it will generally be preferable to take postmortem samples at slaughter rather than to obtain biopsy specimens from live animals. Postmortem sampling additionally allows large samples to be obtained, enabling histologic study, and at the same time, routine postmortem testing allows parallel evaluation of potential health risk for liver consumers.
